{"database": "lobbying", "table": "lobbying_activities", "is_view": false, "human_description_en": "where filing_uuid = \"5dfd0530-8a0b-4713-9d2e-b86105d8a8a8\" and issue_code = \"DEF\" sorted by filing_year descending", "rows": [[1145552, "5dfd0530-8a0b-4713-9d2e-b86105d8a8a8", "Q3", "DALRYMPLE & ASSOCIATES, LLC", 5073, "DISCOVERY LABORATORIES", 2011, "third_quarter", "DEF", "Small peptide synthetic lung surfactant and delivery devices CBRN threat medical countermeasures research and development defense agency grant and contract funding opportunities, legislation, appropriations and oversight.", "Army, Dept of (Other),Ballistic Missile Defense Organization,Centers For Disease Control & Prevention (CDC),Defense, Dept of (DOD),Defense Threat Reduction Agency (DTRA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,White House Office", 20000, null, 0, 0, "2011-10-07T14:40:34.010000-04:00"]], "truncated": false, "filtered_table_rows_count": 1, "expanded_columns": [], "expandable_columns": [[{"column": "filing_uuid", "other_table": "lobbying_filings_raw", "other_column": "filing_uuid"}, "registrant_name"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, filing_uuid, filing_type, registrant_name, registrant_id, client_name, filing_year, filing_period, issue_code, specific_issues, government_entities, income_amount, expense_amount, is_no_activity, is_termination, received_date from lobbying_activities where \"filing_uuid\" = :p0 and \"issue_code\" = :p1 order by filing_year desc limit 101", "params": {"p0": "5dfd0530-8a0b-4713-9d2e-b86105d8a8a8", "p1": "DEF"}}, "facet_results": {"issue_code": {"name": "issue_code", "type": "column", "hideable": false, "toggle_url": "/lobbying/lobbying_activities.json?filing_uuid=5dfd0530-8a0b-4713-9d2e-b86105d8a8a8&issue_code=DEF", "results": [{"value": "DEF", "label": "DEF", "count": 1, "toggle_url": "https://www.pawtectors.org/lobbying/lobbying_activities.json?filing_uuid=5dfd0530-8a0b-4713-9d2e-b86105d8a8a8", "selected": true}], "truncated": false}, "filing_year": {"name": "filing_year", "type": "column", "hideable": false, "toggle_url": "/lobbying/lobbying_activities.json?filing_uuid=5dfd0530-8a0b-4713-9d2e-b86105d8a8a8&issue_code=DEF", "results": [{"value": 2011, "label": 2011, "count": 1, "toggle_url": "https://www.pawtectors.org/lobbying/lobbying_activities.json?filing_uuid=5dfd0530-8a0b-4713-9d2e-b86105d8a8a8&issue_code=DEF&filing_year=2011", "selected": false}], "truncated": false}, "filing_period": {"name": "filing_period", "type": "column", "hideable": false, "toggle_url": "/lobbying/lobbying_activities.json?filing_uuid=5dfd0530-8a0b-4713-9d2e-b86105d8a8a8&issue_code=DEF", "results": [{"value": "third_quarter", "label": "third_quarter", "count": 1, "toggle_url": "https://www.pawtectors.org/lobbying/lobbying_activities.json?filing_uuid=5dfd0530-8a0b-4713-9d2e-b86105d8a8a8&issue_code=DEF&filing_period=third_quarter", "selected": false}], "truncated": false}}, "suggested_facets": [{"name": "received_date", "type": "date", "toggle_url": "https://www.pawtectors.org/lobbying/lobbying_activities.json?filing_uuid=5dfd0530-8a0b-4713-9d2e-b86105d8a8a8&issue_code=DEF&_facet_date=received_date"}], "next": null, "next_url": null, "private": false, "allow_execute_sql": true, "query_ms": 56.0396279906854, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}